Robert K. Suter

Drug and disease signature integration identifies synergistic combinations in glioblastoma

Nicholas J. Lyons, Michael A. Durante, T. Golub, 2018, Nature Communications.

A multiparametric pharmacogenomic strategy for drug repositioning predicts therapeutic efficacy for glioblastoma cell lines.

M. Gilbert, J. Heiss, Vasileios Stathias, 2021, Neuro-oncology advances.